Inventor · disambiguated record
Michael Deligny
Also filed as: DELIGNY MICHAEL · DELIGNY MICHAEL LOUIS ROBERT
14 granted patents·7 pending applications·34 citations·filing 2008–2024
88Inventor score
Top patents by PatentIndex Score
21 records- 0185US10906919B2Fused pentacyclic imidazole derivativesUCB Biopharma SRL·Filed 2018·Granted Feb 2, 2021·2 cites·10 claims
- 0284US10087179B2Fused tricyclic imidazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Oct 2, 2018·8 cites·11 claims
- 0384US9932343B2Fused tricyclic benzimidazoles derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Apr 3, 2018·10 cites·16 claims
- 0483US9890174B2Fused Tricyclic imidazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Feb 13, 2018·8 cites·16 claims
- 0582US10202405B2Fused pentacyclic imidazole derivativesUCB BIOPHARMA SPRL·Filed 2015·Granted Feb 12, 2019·4 cites·11 claims
- 0674US9926313B2Imidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Mar 27, 2018·2 cites·8 claims
- 0773US2023348384A1Aza (Indole)-, Benzothiophene-, And Benzofuran-3-SulfonamidesUCB PHARMA GMBH·Filed 2023·Application pending·0 cites
- 0867US12071404B2Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamidesUCB PHARMA GMBH·Filed 2021·Granted Aug 27, 2024·0 cites·58 claims
- 0967US11912721B2Fused pentacyclic imidazole derivativesUCB Biopharma SRL·Filed 2020·Granted Feb 27, 2024·0 cites·16 claims
- 1067US11820746B2Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamidesUCB PHARMA GMBH·Filed 2022·Granted Nov 21, 2023·0 cites·34 claims
- 1158US2024400581A1Process for Preparing a Macrocyclic Compound Having ENT1 Inhibiting ActivityiTeos Belgium SA·Filed 2024·Application pending·0 cites
- 1256US11345662B2Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamidesUCB PHARMA GMBH·Filed 2017·Granted May 31, 2022·0 cites·47 claims
- 1355US2023407352A1Method for the Production of Thiocarbamate Derivatives A2AR InhibitorsiTeos Belgium SA·Filed 2021·Application pending·0 cites
- 1455US2024368183A1Macrocyclic Compounds Having ENT1 Inhibiting ActivityiTeos Belgium SA·Filed 2024·Application pending·0 cites
- 1553US2023146675A1PYRIMIDO[5,4-d]PYRIMIDINE DERIVATIVES AS ENT INHIBITORS FOR THE TREATMENT OF CANCERS, AND COMBINATION THEREOF WITH ADENOSINE RECEPTOR ANTAGONISTSiTeos Belgium SA·Filed 2022·Application pending·0 cites
- 1646US2023203058A1Macrocyclic diamine derivatives as ent inhibitors for the treatment of cancers, and combination thereof with adenosine receptor antagonistsiTeos Belgium SA·Filed 2021·Application pending·0 cites
- 1742US10766906B2Fused hexacyclic imidazole derivatives as modulators of TNF activityUCB Biopharma SRL·Filed 2017·Granted Sep 8, 2020·0 cites·5 claims
- 1841US2010292214A1Compounds with Antiparasitic Activity, Applications thereof to the Treatment of Infectious Diseases Caused by ApicomplexansCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2008·Application pending·0 cites
- 1940US10669286B2Fused pentacyclic imidazole derivatives as modulators of TNF activityUCB Biopharma SRL·Filed 2017·Granted Jun 2, 2020·0 cites·10 claims
- 2039US8637496B2Compounds having a monogalactosyldiacylglycerol synthase inhibitory activity as herbicide or algaecide, herbicide and algaecide compositionsBONNEAU ANNE-LAURE·Filed 2008·Granted Jan 28, 2014·0 cites·15 claims
- 2138US10654861B2Fused pentacyclic imidazole derivatives as modulators of TNF activityUCB Biopharma SRL·Filed 2017·Granted May 19, 2020·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Michael Deligny files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →